Lmr Partners LLP Applied Therapeutics Inc. Put Options Transaction History

Lmr Partners LLP

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 07, 2024	BUY	$4.35 - $8.5 $97,004 - $189,550	22,300 Added 44.6%	72,300 $614,000
Q2 2024 Aug 14, 2024	SELL	$4.04 - $6.37 $417,736 - $658,658	-103,400 Reduced 67.41%	50,000 $233,000
Q1 2024 May 15, 2024	BUY	$2.25 - $7.4 $76,275 - $250,860	33,900 Added 28.37%	153,400 $1.04 Million
Q4 2023 Feb 14, 2024	BUY	$1.84 - $3.35 $219,880 - $400,325	119,500 New	119,500 $400,000

140

112M

1.68M

1.91M

Ticker APLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,700
Market Cap $29.3M
Description
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.